- Home
- INM vs MFC Comparison
INM vs MFC Comparison
Compare INM & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- MFC
- Stock Information
- Founded
- INM 1981
- MFC 1887
- Country
- INM Canada
- MFC Canada
- Employees
- INM N/A
- MFC N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- MFC Life Insurance
- Sector
- INM Health Care
- MFC Finance
- Exchange
- INM Nasdaq
- MFC Nasdaq
- Market Cap
- INM 4.3M
- MFC 51.7B
- IPO Year
- INM N/A
- MFC 1999
- Fundamental
- Price
- INM $2.20
- MFC $32.06
- Analyst Decision
- INM
- MFC Buy
- Analyst Count
- INM 0
- MFC 1
- Target Price
- INM N/A
- MFC $49.00
- AVG Volume (30 Days)
- INM 40.0K
- MFC 2.2M
- Earning Date
- INM 11-13-2025
- MFC 11-05-2025
- Dividend Yield
- INM N/A
- MFC 3.83%
- EPS Growth
- INM N/A
- MFC 33.03
- EPS
- INM N/A
- MFC 2.29
- Revenue
- INM $4,920,990.00
- MFC $22,915,108,577.00
- Revenue This Year
- INM N/A
- MFC $34.27
- Revenue Next Year
- INM N/A
- MFC $8.25
- P/E Ratio
- INM N/A
- MFC $13.55
- Revenue Growth
- INM N/A
- MFC 9.72
- 52 Week Low
- INM $1.72
- MFC $25.92
- 52 Week High
- INM $8.27
- MFC $33.07
- Technical
- Relative Strength Index (RSI)
- INM 45.89
- MFC 66.43
- Support Level
- INM $2.11
- MFC $30.49
- Resistance Level
- INM $2.28
- MFC $31.04
- Average True Range (ATR)
- INM 0.10
- MFC 0.42
- MACD
- INM 0.02
- MFC 0.18
- Stochastic Oscillator
- INM 62.96
- MFC 97.81
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About MFC Manulife Financial Corporation
Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings and is one of the top 20 life insurers in the US. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.